Most of the patients (77%) diagnosed with cervical cancer had a CD4+ T-cell count >200 cells/mm3 and almost half of them (44%) had a nadir CD4+ count >200 cell/mm3. The gene discussed is CD4; the disease is cervical carcinoma.